© 2018 Miraculo Inc. All Rights Reserved
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.
Cannabinoids are chemical compounds that are located in the cannabis plant (cannabis sativa). Cannabidiol (CBD) is one of these chemicals and studies have shown it has anti inflammatory effects when induced on animal cells. People have smoked the marijuana plant for thousands of years and it is said to have an anti inflammatory role in the body. Tetrahydrocannabinol (THC) is another one of these chemicals and it is said it has psychoactive effects. Major cannabinoid receptors (CB1 and CB2) are found in the endocannabinoid system and allow exogenous and endogenous cannabinoids to thrive in the body. This paper will review cannabis and its constituents in the treatment of disorders arising from crack-cocaine addiction.
CBD has antipsychotic properties
A detrimental therapeutic possibility for crack-cocaine use may be cannabinoids, which in recent times have been seen to become very popular in the therapeutic treatment of neurological diseases. Distinct possible therapeutic advantages for crack-cocaine use and normal related side effect symptoms may arise specifically from cannabidiol with its known anxiolytic, anti-psychotic, anti-convulsant effects and possible benefits for sleep and appetite disorders. The potential therapeutic value of cannabinoids are corroborated by numerous studies from different contexts reporting crack-cocaine users’ trying to ‘self-medicate’ towards coping with crack-cocaine-related syndromes,including withdrawal and craving, impulsivity and paranoia. Cannabinoid therapeutics are beneficial because they can be administered in a lot of different ways and they offer a low risk form of treatment.
Cannabis may be therapeutic against cocaine use
Feasible and efficient therapeutic options for crack-cocaine use are desperately needed. Based on recent evidence for the many therapeutic possibilities of, as well as the observational data on crack-cocaine users’ ‘self-medication’ efforts with cannabinoids, it is fair to say that there may indeed be conflicting valuable therapeutic advantages for crack-cocaine use. There are a number of benefits to cannabinoid drugs that render experimental therapeutic interventions pretty easy and feasible. None of the THC and CBD cannabinoid products withhold risks for bad side effects and they also offer various routes of administration. These routes may be detrimental simply for keeping crack-cocaine users in line with their cannabinoid prescription. While it may be not wise to call cannabinoids a cure for crack-cocaine use, specific formulations may give valuable therapeutic relief to crack-cocaine user to reduce the nasty adverse physical and psychological problem symptoms distinct for crack-cocaine use which greatly affect both many users and their social environments. The Director of the NIH’s National Institute on Drug Abuse (NIDA), Dr. Nora Volkow, in a recent speech to the US Senate (24 June 2015), said that “high CBD doses may have therapeutic value as a treatment of substance use disorders” and emphasized the “need for rigorous clinical research in this area.”
Overall, it seems that people who smoke crack have a range of treatment options with plenty of support groups in treatment centers across the country for their crack addiction. If these treatment facilities and treatment programs do not work, then the therpaeutic use of cannabis strains could be important.PIIS095539591500300X